These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 26048638)

  • 1. Hepatitis C virus infection and pain sensitivity in patients on methadone or buprenorphine maintenance therapy for opioid use disorders.
    Tsui JI; Lira MC; Cheng DM; Winter MR; Alford DP; Liebschutz JM; Mao J; Edwards RR; Samet JH
    Drug Alcohol Depend; 2015 Aug; 153():286-92. PubMed ID: 26048638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV And HCV infection among opiate-dependent patients and methadone doses: the PROTEUS study.
    Roncero C; Fuster D; Palma-Álvarez RF; Rodriguez-Cintas L; Martinez-Luna N; Álvarez FJ
    AIDS Care; 2017 Dec; 29(12):1551-1556. PubMed ID: 28393548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization of buprenorphine and methadone among opioid users who inject drugs.
    Tsui JI; Burt R; Thiede H; Glick SN
    Subst Abus; 2018 Jan; 39(1):83-88. PubMed ID: 28796591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic Safety of Buprenorphine in HIV-Infected and Uninfected Patients With Opioid Use Disorder: The Role of HCV-Infection.
    Tetrault JM; Tate JP; Edelman EJ; Gordon AJ; Lo Re V; Lim JK; Rimland D; Goulet J; Crystal S; Gaither JR; Gibert CL; Rodriguez-Barradas MC; Fiellin LE; Bryant K; Justice AC; Fiellin DA
    J Subst Abuse Treat; 2016 Sep; 68():62-7. PubMed ID: 27431048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-morbid pain and opioid addiction: long term effect of opioid maintenance on acute pain.
    Wachholtz A; Gonzalez G
    Drug Alcohol Depend; 2014 Dec; 145():143-9. PubMed ID: 25456326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methadone and buprenorphine-naloxone are effective in reducing illicit buprenorphine and other opioid use, and reducing HIV risk behavior--outcomes of a randomized trial.
    Otiashvili D; Piralishvili G; Sikharulidze Z; Kamkamidze G; Poole S; Woody GE
    Drug Alcohol Depend; 2013 Dec; 133(2):376-82. PubMed ID: 23916321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic pain, craving, and illicit opioid use among patients receiving opioid agonist therapy.
    Tsui JI; Lira MC; Cheng DM; Winter MR; Alford DP; Liebschutz JM; Edwards RR; Samet JH
    Drug Alcohol Depend; 2016 Sep; 166():26-31. PubMed ID: 27422763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of opioid agonist therapy with lower incidence of hepatitis C virus infection in young adult injection drug users.
    Tsui JI; Evans JL; Lum PJ; Hahn JA; Page K
    JAMA Intern Med; 2014 Dec; 174(12):1974-81. PubMed ID: 25347412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pain intolerance in opioid-maintained former opiate addicts: effect of long-acting maintenance agent.
    Compton P; Charuvastra VC; Ling W
    Drug Alcohol Depend; 2001 Jul; 63(2):139-46. PubMed ID: 11376918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-reported side effects in buprenorphine and methadone patients receiving antiretroviral therapy: results from the MANIF 2000 cohort study.
    Carrieri MP; Roux P; Cohen J; Ravaux I; Dellamonica P; Protopopescu C; Spire B; Rosenblum A
    Addiction; 2010 Dec; 105(12):2160-8. PubMed ID: 20840169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of characteristics and outcomes of opioid-dependent patients initiating office-based buprenorphine or methadone maintenance treatment.
    Fingerhood MI; King VL; Brooner RK; Rastegar DA
    Subst Abus; 2014; 35(2):122-6. PubMed ID: 24821346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of opioid substitution therapies in the treatment of opioid use disorder: results of a UK cost-effectiveness modelling study.
    Kenworthy J; Yi Y; Wright A; Brown J; Maria Madrigal A; Dunlop WCN
    J Med Econ; 2017 Jul; 20(7):740-748. PubMed ID: 28489467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterizing pain and associated coping strategies in methadone and buprenorphine-maintained patients.
    Dunn KE; Finan PH; Tompkins DA; Fingerhood M; Strain EC
    Drug Alcohol Depend; 2015 Dec; 157():143-9. PubMed ID: 26518253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C in a Mobile Low-Threshold Methadone Program.
    Silva MJ; Pereira C; Loureiro R; Balsa C; Lopes P; Água-Doce I; Belo E; Martins HC; Coutinho R; Pádua E
    Eur J Gastroenterol Hepatol; 2017 Jun; 29(6):657-662. PubMed ID: 28151750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid agonist treatment dosage and patient-perceived dosage adequacy, and risk of hepatitis C infection among people who inject drugs.
    Artenie AA; Minoyan N; Jacka B; Høj S; Jutras-Aswad D; Roy É; Gauvin L; Zang G; Bruneau J
    CMAJ; 2019 Apr; 191(17):E462-E468. PubMed ID: 31036608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methadone treatment, severe food insecurity, and HIV-HCV co-infection: A propensity score matching analysis.
    McLinden T; Moodie EEM; Hamelin AM; Harper S; Rossi C; Walmsley SL; Rourke SB; Cooper C; Klein MB; Cox J
    Drug Alcohol Depend; 2018 Apr; 185():374-380. PubMed ID: 29544189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C Virus Testing and Treatment Among Persons Receiving Buprenorphine in an Office-Based Program for Opioid Use Disorders.
    Carey KJ; Huang W; Linas BP; Tsui JI
    J Subst Abuse Treat; 2016 Jul; 66():54-9. PubMed ID: 26988423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of hepatitis C virus status on liver enzymes in opioid-dependent pregnant women maintained on opioid-agonist medication.
    McNicholas LF; Holbrook AM; O'Grady KE; Jones HE; Coyle MG; Martin PR; Heil SH; Stine SM; Kaltenbach K
    Addiction; 2012 Nov; 107 Suppl 1(0 1):91-7. PubMed ID: 23106931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recommendations for buprenorphine and methadone therapy in opioid use disorder: a European consensus.
    Dematteis M; Auriacombe M; D'Agnone O; Somaini L; Szerman N; Littlewood R; Alam F; Alho H; Benyamina A; Bobes J; Daulouede JP; Leonardi C; Maremmani I; Torrens M; Walcher S; Soyka M
    Expert Opin Pharmacother; 2017 Dec; 18(18):1987-1999. PubMed ID: 29183228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Examination of the Hepatitis C Virus care continuum among individuals with an opioid use disorder in substance use treatment.
    Brown JL; Gause NK; Lewis D; Winhusen T
    J Subst Abuse Treat; 2017 May; 76():77-80. PubMed ID: 28162850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.